Jessica J. Federer

Jessica J. Federer is a highly esteemed independent board member for various public and private companies, renowned for her expertise in digital transformation, health technologies, and women's health.

Currently serving on the board of Sage Therapeutics (SAGE), Pluto Health, and Aspivix, she has extensive experience in the healthcare and technology sectors, with a strong focus on advancing human health and well-being.

She is also a key figure on the board of directors for Angelini Ventures, where she contributes to investments that have a positive impact on human health, showcasing her commitment to driving innovation and progress in the industry.

In her previous role as Chief Digital Officer at Bayer AG, Ms. Federer spearheaded a comprehensive digital transformation initiative across multiple business divisions, including Pharmaceutical, Consumer Care, Crop Science, and Animal Health, solidifying her reputation as a leader in the field.

Furthermore, she holds the position of an external senior advisor at McKinsey, advising a wide array of companies ranging from Fortune Global 100 corporations to disruptive startups, highlighting her versatility and strategic acumen.

During the challenging times of the pandemic, Jessica joined Huma, Europe's fastest-growing digital health company, as Managing Director, leading the expansion of decentralized clinical trials for international Covid-19 vaccine studies in the United States, showcasing her ability to drive impactful change and innovation in critical times.

Maintaining an active role within the investment community, she chairs the New York Stock Exchange Women's Health Investor Summit, bringing together influential investors to discuss crucial matters in women's health, and is a member of the Investment Collaborative for Women's Health Access Matters, underscoring her dedication to promoting women's health globally.

Beyond her corporate engagements, Ms. Federer is deeply involved in academic and advisory roles, serving on the Yale Ventures Blavatnik Advisor board and the Yale Institutional Review Board, which demonstrates her commitment to fostering innovation and excellence in academia.

Her professional journey began at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services, reflecting her early dedication to public health and her continuous commitment to making a positive impact in the healthcare landscape.

Jessica holds a Bachelor of Science from The George Washington University, a Master of Public Health from Yale School of Public Health, and has also pursued academic endeavors at the University of Oxford, showcasing her strong educational background and commitment to continuous learning and growth.